These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31838149)

  • 1. Lipopolysaccharide-induced inflammation leads to acute elevations in pro-inflammatory cytokine expression in a mouse model of Fragile X syndrome.
    Hodges SL; Nolan SO; Tomac LA; Muhammad IDA; Binder MS; Taube JH; Lugo JN
    Physiol Behav; 2020 Mar; 215():112776. PubMed ID: 31838149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult Fmr1 knockout mice present with deficiencies in hippocampal interleukin-6 and tumor necrosis factor-α expression.
    Hodges SL; Nolan SO; Taube JH; Lugo JN
    Neuroreport; 2017 Dec; 28(18):1246-1249. PubMed ID: 28915148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in CA1 hippocampal synapses in a mouse model of fragile X syndrome.
    Jawaid S; Kidd GJ; Wang J; Swetlik C; Dutta R; Trapp BD
    Glia; 2018 Apr; 66(4):789-800. PubMed ID: 29274095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
    Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
    Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group I metabotropic glutamate receptor mediated dynamic immune dysfunction in children with fragile X syndrome.
    Careaga M; Noyon T; Basuta K; Van de Water J; Tassone F; Hagerman RJ; Ashwood P
    J Neuroinflammation; 2014 Jun; 11():110. PubMed ID: 24942544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide-induced sickness behavior is not altered in male Fmr1-deficient mice.
    Santana-Coelho D; Hodges SL; Quintero SI; Womble PD; Sullens DG; Narvaiz DA; Herrera R; Sekeres MJ; Lugo JN
    Brain Behav; 2023 Aug; 13(8):e3142. PubMed ID: 37407501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome.
    Spencer CM; Alekseyenko O; Serysheva E; Yuva-Paylor LA; Paylor R
    Genes Brain Behav; 2005 Oct; 4(7):420-30. PubMed ID: 16176388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome.
    Maurin T; Melancia F; Jarjat M; Castro L; Costa L; Delhaye S; Khayachi A; Castagnola S; Mota E; Di Giorgio A; Servadio M; Drozd M; Poupon G; Schiavi S; Sardone L; Azoulay S; Ciranna L; Martin S; Vincent P; Trezza V; Bardoni B
    Cereb Cortex; 2019 Jul; 29(8):3241-3252. PubMed ID: 30137253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism.
    Zieba J; Sinclair D; Sebree T; Bonn-Miller M; Gutterman D; Siegel S; Karl T
    Pharmacol Biochem Behav; 2019 Jun; 181():93-100. PubMed ID: 31063743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic inhibition of phosphodiesterase-4D on behavior and regional rates of cerebral protein synthesis in a mouse model of fragile X syndrome.
    Rosenheck M; Sheeler C; Saré RM; Gurney ME; Smith CB
    Neurobiol Dis; 2021 Nov; 159():105485. PubMed ID: 34411704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.
    Han K; Chen H; Gennarino VA; Richman R; Lu HC; Zoghbi HY
    Hum Mol Genet; 2015 Apr; 24(7):1813-23. PubMed ID: 25432536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic reduction of MMP-9 in the Fmr1 KO mouse partially rescues prepulse inhibition of acoustic startle response.
    Kokash J; Alderson EM; Reinhard SM; Crawford CA; Binder DK; Ethell IM; Razak KA
    Brain Res; 2019 Sep; 1719():24-29. PubMed ID: 31128097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of ultrasonic vocalization deficits in a mouse model of Fragile X Syndrome with minocycline treatment or genetic reduction of MMP-9.
    Toledo MA; Wen TH; Binder DK; Ethell IM; Razak KA
    Behav Brain Res; 2019 Oct; 372():112068. PubMed ID: 31271818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Training Intensity Induces Proper Membrane Localization of Actin Remodeling Proteins in the Hippocampus Preventing Cognitive Deficits: Implications for Fragile X Syndrome.
    Martinez LA; Tejada-Simon MV
    Mol Neurobiol; 2018 Jun; 55(6):4529-4542. PubMed ID: 28688003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome.
    Nosyreva ED; Huber KM
    J Neurophysiol; 2006 May; 95(5):3291-5. PubMed ID: 16452252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice.
    Michalon A; Bruns A; Risterucci C; Honer M; Ballard TM; Ozmen L; Jaeschke G; Wettstein JG; von Kienlin M; Künnecke B; Lindemann L
    Biol Psychiatry; 2014 Feb; 75(3):189-97. PubMed ID: 23910948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocyte-mediated purinergic signaling is upregulated in a mouse model of Fragile X syndrome.
    Reynolds KE; Wong CR; Scott AL
    Glia; 2021 Jul; 69(7):1816-1832. PubMed ID: 33754385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of Fragile X syndrome.
    Yuskaitis CJ; Beurel E; Jope RS
    Biochim Biophys Acta; 2010 Nov; 1802(11):1006-12. PubMed ID: 20600866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal development of auditory responses in the inferior colliculus of a mouse model of Fragile X Syndrome.
    Nguyen AO; Binder DK; Ethell IM; Razak KA
    J Neurophysiol; 2020 Jun; 123(6):2101-2121. PubMed ID: 32319849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of GluN2A NMDA receptors ameliorates synaptic plasticity deficits in the Fmr1
    Lundbye CJ; Toft AKH; Banke TG
    J Physiol; 2018 Oct; 596(20):5017-5031. PubMed ID: 30132892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.